City
Epaper

SII not allowed to conduct phase 2 & 3 clinical trials of Covavax vaccine on children

By Lokmat English Desk | Updated: July 1, 2021 10:23 IST

Pune's Serum Institute, which has come under a lot of discussion due to Covishield, has suffered a major setback. ...

Open in App

Pune's Serum Institute, which has come under a lot of discussion due to Covishield, has suffered a major setback. The government panel has recommended against allowing Serum Institute of India to conduct phase 2 & 3 clinical trials of Covavax COVID-19 vaccine on children of age 2-17 years. The government panel has asked Serum Institute of India to complete trials of Covavax COVID-19 vaccine on adults first. Serum had sought permission from the Drug Controller General of India to test the vaccine on children.

The third wave of corona is said to affect children the most. This has led to speeding up work on vaccines for young children.

“The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO), which deliberated on the application, noted that the vaccine has not been approved in any country," a source said. “It also recommended that the Pune-based company should submit the safety and immunogenicity data (of Covovax) from the ongoing clinical trial in adults for considering the conduct of a clinical trial in children," the source said.

The committee said that before the Serum sought permission to test the Covavax vaccine on children, it was necessary to present the effects of the vaccine on adults and test data. DCGI has approved testing of this vaccine on adults.

However, this objection has been raised as the Serum has sought permission to test on young children without submitting data on the results of this vaccine. Zydus Cadila, on the other hand, who passed the third test stage, has asked the DCGI for permission to use the DNA vaccine for children over 12 years of age.

Tags: Serum Institute Of IndiaCovavax vaccineCovishield
Open in App

Related Stories

PunePune Accident: Mercedes-Owned by Serum Institute of India Driver Arrested, Victims Kin Demands Justice

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalAkhilesh Yadav Attacks BJP on Issue of Covishield Vaccine Side Effect, Says 'People Who Got Injection Will Vote Against Party'

National Realted Stories

NationalThings won't work like this: Delhi CM slams officials during visit to waterlogged Majnu Ka Tila

NationalFour killed as bus overturns in MP; CM Yadav announces Rs 2 lakh ex-gratia to bereaved families

NationalKerala Minister elated after Karan Adani praised his role in resolving Vizhinjam port issues

NationalAssam panchayat polls: More than 10 pc voting in first two hours

NationalNepal Foreign Affairs Minister expresses grief over death of Nepali student at Odisha's KIIT University